Results 191 to 200 of about 3,841,835 (347)

Drug-disease networks and drug repurposing. [PDF]

PLoS Comput Biol
Polanco A, Newman MEJ.
europepmc   +1 more source

Low‐intervention clinical trials in Spain: Do they progress?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza, Mayro J. Cortés Pestana, Kristopher Amaro, Rosa M. Antonijoan, Caridad Pontes   +4 more
wiley   +1 more source

Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation. [PDF]

Alzheimers Res Ther
Corbett A, Sultana J, Stych K, Mills R, Cummings JL, Williams G, Ismail Z, Soto-Martin M, Mintzer J, Gauthier S, Greig NH, Noble W, Killick R, Lai MKP, Routledge C, Walsh F, Fillit H, Aarsland D, Lane R, Mills K, Ballard C.   +20 more
europepmc   +1 more source

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing [PDF]

, 2020
Oleg O. Glebov
openalex   +1 more source

Anesthetic Drug Repurposing

Bali Journal of Anesthesiology, 2021
Jasvinder Kaur Kohli, Rohan Magoon, Iti Shri, Ramesh Chand Kashav   +3 more
openaire   +2 more sources

A Natural Resource‐Based View of Circular Economy Practices in the Pharmaceutical Industry

Business Strategy and the Environment, EarlyView.
ABSTRACT Pharmaceutical industry is facing escalating environmental sustainability issues including gaseous emissions, waste generation, and excessive consumption of energy and non‐renewable materials. Nevertheless, the adoption of sustainable business models such as the circular economy (CE) is still in its infancy in this sector due to complex ...
Amna Farrukh, Muhammad Sohaib Sajjad
wiley   +1 more source

RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases [PDF]

Lang Qin, Zhihua Gan, Xu Cao, Pengcheng Jiang, Yong Jiang, Jianbin Han, Kaishun Wu, Jintai Chen   +7 more
openalex   +1 more source

More Than 10 Years on: Does a State‐of‐the‐Art Review and Synthesis Offer New Frameworks to Guide Future Design for Remanufacturing Research?

Business Strategy and the Environment, EarlyView.
ABSTRACT There is strong evidence that design for remanufacturing (DfRem) can reduce initial‐design carbon emissions by up to 30%, and that product design can critically affect remanufacturing feasibility, yet academic adoption of DfRem remains limited.
Okechukwu Okorie, Yogendra Singh, Jennifer Russell, Chris Turner, Kingsley Oturu   +4 more
wiley   +1 more source

Drug repurposing in cancer research: a bibliometric analysis. [PDF]

Discov Oncol
Ndidi US, Ogra IO, Jonathan EU, Iroha OK.   +3 more
europepmc   +1 more source

Image analysis method for measurement and prediction of intra‐matrix IgG diffusion

Biotechnology Progress, EarlyView.
Experimental and image analysis workflow for b‐IgG diffusion in hyaluronic acid (HA) matrix. Abstract Measurement and imaging of intra‐matrix protein therapeutics diffusion is important due to the emergence of injectable biologics currently in various stages of research and clinical testing.
Riya Debbarma, Antonio C. F. dos Santos, Michael Ladisch   +2 more
wiley   +1 more source